SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-171476
Filing Date
2020-06-17
Accepted
2020-06-17 17:21:33
Documents
5
Period of Report
2020-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d949850d8k.htm 8-K 23494
2 EX-1.1 d949850dex11.htm EX-1.1 203618
3 EX-5.1 d949850dex51.htm EX-5.1 11434
4 EX-99.1 d949850dex991.htm EX-99.1 10910
5 GRAPHIC g949850g75o04.jpg GRAPHIC 1972
  Complete submission text file 0001193125-20-171476.txt   253490
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38584 | Film No.: 20970579
SIC: 2834 Pharmaceutical Preparations